Contact
Please use this form to send email to PR contact of this press release:
Dermaliq Therapeutics announces first patient dosed in Phase 1b/2 trial evaluating DLQ02 for treatment of plaque psoriasis
TO:
Please use this form to send email to PR contact of this press release:
Dermaliq Therapeutics announces first patient dosed in Phase 1b/2 trial evaluating DLQ02 for treatment of plaque psoriasis
TO: